Wells Fargo & Company »

Regulus Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $42k 27k 1.57
2024-06-30 $47k 26k 1.83
2024-03-31 $402 142 2.83
2023-12-31 $186 140 1.33
2023-09-30 $175 128 1.37
2023-06-30 $186 127 1.47
2022-12-31 $126 92 1.37
2022-09-30 $0 90 0.00
2022-06-30 $0 718 0.00